首页> 外文期刊>European journal of nuclear medicine >Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy.
【24h】

Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy.

机译:多巴酚丁胺应力超声心动图与tech 99m sestamibi单光子发射断层显像在诊断左室肥厚和无左室肥厚的冠状动脉疾病中的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Stress echocardiography has been considered an accurate method for the diagnosis of coronary artery disease in hypertensive patients and in patients with left ventricular hypertrophy. In contrast, the specificity of myocardial perfusion scintigraphy in these patients has been questioned. The aim of this study was to compare the accuracy of these two imaging modalities in conjunction with dobutamine stress test for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophy. Dobutamine (up to 40 microg kg-1min-1) stress echocardiography in conjunction with sestamibi (MIBI) single-photon emission tomography (SPET) was performed in 84 patients with the diagnosis of systemic hypertension who had been referred for evaluation of myocardial ischaemia. Ischaemia was defined as new or worsened wall motion abnormalities at echocardiography and reversible perfusion defects at SPET. Significant coronary artery disease (>/=50% luminal diameter stenosis) was detected in 66 patients (79%). The sensitivity, specificity and accuracy of the ischaemic pattern at echocardiography for the diagnosis of coronary artery disease were 73% (CI 63%-82%), 83% (CI 75%-91%) and 75% (CI 66%-84%), those for MIBI were 67% (CI 57%-77%), 83% (CI 75%-91%) and 70% (CI 60%-80%) respectively (P = NS vs echocardiography). Significant stenosis was detected in 123 (49%) of the 252 analysed coronary arteries. The sensitivity, specificity and accuracy of echocardiography for the regional diagnosis of coronary artery disease were 63% (CI 56%-69%), 90% (CI 86%-94%) and 77% (CI 72%-82%). Those for MIBI were 58% (CI 51%-64%), 91% (CI 87%-94%) and 75% (CI 69%-80) respectively (P = NS vs echocardiography). Left ventricular hypertrophy was detected in 59 patients (70%) by echocardiography and did not influence the overall or regional specificity of echocardiography or MIBI SPET. It is concluded that in hypertensive patients, dobutamine stress echocardiography and MIBI SPET have a comparable accuracy for the overall and regional diagnosis of coronary artery disease. Hypertensive patients with or without left ventricular hypertrophy should not be considered unsuitable candidates for stress myocardial perfusion scintigraphy.
机译:应力超声心动图已被认为是诊断高血压患者和左心室肥厚患者冠状动脉疾病的准确方法。相反,在这些患者中心肌灌注闪烁显像的特异性受到质疑。这项研究的目的是比较多巴酚丁胺负荷试验结合这两种成像方式对患有或不伴有左心室肥厚的高血压患者的冠状动脉疾病的诊断准确性。多巴酚丁胺(高达40 microg kg-1min-1)的应力超声心动图与sestamibi(MIBI)单光子发射断层扫描(SPET)结合,对84例系统性高血压的诊断患者进行了评估,这些患者已被推荐用于评估心肌缺血。缺血被定义为超声心动图上出现的新的或恶化的壁运动异常以及SPET上可逆的灌注缺陷。在66名患者(79%)中检测到严重的冠状动脉疾病(> / = 50%的管腔狭窄)。超声心动图检查缺血模式对冠状动脉疾病的敏感性,特异性和准确性分别为73%(CI 63%-82%),83%(CI 75%-91%)和75%(CI 66%-84) %),MIBI分别为67%(CI 57%-77%),83%(CI 75%-91%)和70%(CI 60%-80%)(P = NS vs超声心动图)。在分析的252条冠状动脉中,有123条(49%)被发现有明显狭窄。超声心动图对冠状动脉疾病区域诊断的敏感性,特异性和准确性分别为63%(CI 56%-69%),90%(CI 86%-94%)和77%(CI 72%-82%)。 MIBI者分别为58%(CI 51%-64%),91%(CI 87%-94%)和75%(CI 69%-80)(P = NS vs超声心动图)。超声心动图检查发现59例患者(70%)左室肥厚,并不影响超声心动图或MIBI SPET的整体或区域特异性。结论是,在高血压患者中,多巴酚丁胺负荷超声心动图和MIBI SPET对冠状动脉疾病的整体和区域诊断具有可比的准确性。有或没有左心室肥厚的高血压患者不应被认为不适合作为应激性心肌灌注显像的候选人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号